Intravenous human immune globulin (Gammagard) developed by Baxter Inc could help preventing brain shrinkage in Alzheimer's disease patients.
Aurobindo Pharma Limited, a leading APIs an generics player from India, has received the final approval for ondansetron orally disintegrating tablets (ODT) from US FDA.
Gennova Biopharmaceuticals has launched the bio similar pegfilgrastim Pegex for the treatment of cancer patients in India.
Obeticholic acid, an experimental drug developed by Intercept Pharmaceuticals, can help in the treatment of primary biliary cirrhosis at EASL.
India will be one of the top 10 sales markets by 2020, according to a report by PricewaterhouseCoopers (PwC), Global pharma looks to India: Prospects for growth.
Venus Remedies may launch a diagnostic product VRP 1620 (endothelin) to detect cancer in Indian soon, reports said.
GlaxoSmithKline LLC has settled out of court a patent dispute with Glenmark on the generic version of its anti-malarial Malarone tablets.
Dextromethorphan/quinidine (Zenvia) is safe and effective in treating the neurologic disease Pseudobulbar affect (PBA), annouced Avanir Pharmaceuticals, Inc.
Novartis investigational multiple sclerosis therapy Gilenia (FTY720) could become the first oral therapy against multiple sclerosis (MS).